March 26, 2026 - 22:54

New York City's public hospital system has unveiled a major $2.75 million initiative aimed at strengthening obstetric care and improving outcomes for mothers and newborns. The significant investment will fund the implementation of advanced electronic fetal monitoring technology across several facilities.
The cornerstone of the program is the integration of PeriGen's PeriWatch system, a sophisticated software platform designed to assist clinicians. This technology provides enhanced, data-driven surveillance during labor and delivery. It analyzes complex fetal heart rate and labor progression patterns, offering clinical decision support to help healthcare teams identify potential concerns earlier and more consistently.
Hospital officials emphasized that the primary goal is to support their clinical staff with state-of-the-art tools, thereby promoting safer births. The initiative reflects a dedicated focus on reducing health disparities and ensuring equitable, high-quality care for all families within the city's public health network. The rollout is scheduled to begin at key hospitals serving a high volume of births, with plans to expand the technology further in the future. This modernization effort marks a substantial commitment to advancing maternal health standards through innovation and sustained investment in frontline care.
April 18, 2026 - 04:30
\'It\'s personal to me\': Bill requiring mental health awareness training for coaches passes in state HouseA bill requiring mental health awareness training for school athletics staff is headed to the Pennsylvania Senate after passing in the state House on Wednesday. The proposed legislation, which...
April 17, 2026 - 03:07
New Leadership Nominated for the Centers for Disease Control and PreventionIn a move to stabilize a key public health agency, Erica Schwartz has been nominated to serve as the next director of the Centers for Disease Control and Prevention. The nomination comes at a...
April 16, 2026 - 02:18
RFK Jr. promotes peptides. Now the FDA weighs easing limits on the unproven chemicalsThe U.S. Food and Drug Administration is moving to re-evaluate its stance on a group of unapproved chemicals known as peptides, following a surge in public interest and promotion by high-profile...
April 15, 2026 - 01:48
Study finds no link between medical gender reassignment and improved mental health among young peopleA comprehensive, register-based study from Finland has delivered findings that challenge prevailing assumptions about medical interventions for gender dysphoria in young people. The research...